Loading...

    Explore
    • Policy Monitoring
    • Live Policy Feed
    • Billing Codes
    • Healthcare Providers
    • Health Insurance Payers
    • States
    • Service Lines
    • Taxonomy Codes
    Lookup tools
    • Billing Code Lookup
    • CPT Modifier Lookup
    • Provider Taxonomy Code Lookup
    • Healthcare Provider & Facility Lookup
    • Health Insurance Payer Lookup
    • Payer Contact Directory

    Policy & Benchmark Tools

    • Prior Authorization Lookup
    • Coverage Criteria Lookup
    • Timely Filing Lookup
    • Billing Code Reimbursement Rates
    • Payer Comparison Dashboard
    • Facility Comparison Dashboard
    • All tools

    Company

    • About OpenPayer
    • Data Sources
    • Trek Health
    OpenPayerby Trek Health
    LinkedInYouTube

    © 2026 Trek Health. All rights reserved.

    OpenPayer is built and maintained by Trek Health.

    v1.0.31
    OpenPayerPolicy UpdatesOtorhinolaryngology (ENT)Regence Eustachian Tube Dilation Coverage | OpenPa…
    Ask Trek AI about this page
    CurrentRegencePolicy 206

    Balloon Dilation of the Eustachian Tube

    Customize your policy alerts

    Sign up for regence Policy 206 alerts

    Get alerted when Policy 206 changes without checking for updates manually.

    Monitor payer policy activity

    Receive email alerts as soon as relevant payer policies are published or updated.

    This policy governs coverage and medical-necessity review for balloon dilation of the Eustachian tube to treat chronic obstructive Eustachian tube dysfunction for Regence members, subject to applicable contract terms and prior authorization requirements.

    Policy Summary
    PayerRegence
    PolicyBalloon Dilation of the Eustachian Tube
    Policy CodePolicy 206
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateMarch 1, 2027
    Key ActionSubmit clinical documentation supporting the medical policy criteria for review.
    SourceLink
    POLICY UPDATE CHANGES

    No material clinical or coverage changes in this revision.

    12 monthsMinimum symptom duration
    4-6 weeksNasal steroid trial when indicated
    Type B or CAbnormal tympanogram
    InvestigationalRepeat procedures

    Medical Necessity and Coverage Determinations

    OpenPayer is powered by Trek Health's payer performance platform. Trek continuously ingests, validates, and normalizes Transparency in Coverage data alongside payer policies and other commercial payer data to create a structured payer intelligence foundation. OpenPayer uses this foundation to deliver personalized search results, dynamically generated policy pages, and tailored policy monitoring based on each user's payers, specialties, billing codes, and areas of interest. The same intelligence powers broader payer performance workflows, including reimbursement benchmarking, contract evaluation, payer negotiations, and financial decision-making.

    Medically Necessary Treatment

    Balloon dilation of the Eustachian tube for treatment of chronic obstructive Eustachian tube dysfunction may be considered medically necessary when <strong>all</strong> of the following criteria are met:

    ALL of the following

    • Age is consistent with the device-specific FDA approval.
    • The individual does not have patulous Eustachian tube dysfunction or another contraindication (see Policy Guidelines).
    • Symptoms have occurred for at least 12 months, including but not limited to aural fullness, aural pressure, otalgia, or hearing loss.>= 12 months
    • The individual does not have other causes of aural fullness, such as temporomandibular joint disorders, extrinsic obstruction of the Eustachian tube, superior semicircular canal dehiscence, or endolymphatic hydrops.
    • Symptoms are continuous rather than episodic, such as symptoms occurring only in response to baro-challenge (for example, pressure changes while flying).
    • Comprehensive diagnostic assessment documents ALL of the following findings

      • Abnormal tympanogram (Type B or C).
      • Abnormal tympanic membrane, including a retracted membrane, effusion, perforation, or any other abnormality identified on examination.
    • The individual has failed to respond to appropriate medical management of co-occurring conditions, including 4–6 weeks of a nasal steroid spray if indicated. Co-occurring conditions include but are not limited to allergic rhinitis, rhinosinusitis, and laryngopharyngeal reflux.4–6 weeks if nasal steroid indicated
    • ONE of the following is met

      • No history of tympanostomy tube placement.
      • History of tympanostomy tube placement with improved symptoms of obstructive Eustachian tube dysfunction while the tubes were patent.
    • ONE of the following is met

      • The individual is younger than 18 years old and is refractory to at least one surgical intervention, such as tympanostomy tubes.
      • The individual is age 18 years or older.

    Not Medically Necessary

    Balloon dilation of the Eustachian tube is considered not medically necessary when Criterion I is not met.

    Criterion I, including all required eligibility and clinical selection criteria, is not met.

    Investigational

    Balloon dilation of the Eustachian tube is considered investigational for the following indications:

    Any of the following

    • Repeat balloon dilation of the Eustachian tube.
    • All other indications.

    There is enough research to show that balloon dilation of the Eustachian tube improves health outcomes in individuals with chronic signs and symptoms under certain circumstances. Additionally, clinical practice guidelines recommend the use of balloon dilation of the Eustachian tube for select individuals. Therefore, the use of balloon dilation of the Eustachian tube may be considered medically necessary for the treatment of Eustachian tube dysfunction when policy criteria are met.

    The following individuals should not be considered for balloon dilation of the Eustachian tube:

    Patulous Eustachian tube dysfunction. A diagnosis of patulous Eustachian tube dysfunction is suggested by symptoms of autophony of voice, audible respirations, pulsatile tinnitus, and/or aural fullness.

    Extrinsic reversible or irreversible causes of Eustachian tube dysfunction, including but not limited to craniofacial syndromes, including cleft palate spectrum; neoplasms causing extrinsic obstruction of the Eustachian tube; history of radiation therapy to the nasopharynx; enlarged adenoid pads; nasopharyngeal mass; neuromuscular disorders that lead to hypotonia or ineffective Eustachian tube dynamic opening; and ongoing or active systemic mucosal or autoimmune inflammatory disease affecting the mucosa of the nasopharynx and Eustachian tube, such as Samter's triad, Wegener's disease, or mucosal pemphigus.

    Individuals with aural fullness but a normal examination and tympanogram.

    Individuals with chronic and severe atelectatic ears.

    Balloon dilation of the Eustachian tube is not medically necessary when the medically necessary policy criteria are not met, including when the individual does not meet the required individual selection criteria.

    Balloon dilation of the Eustachian tube is considered investigational for repeat balloon dilation procedures and for any other indication.

    The diagnosis of obstructive Eustachian tube dysfunction should not be made without a comprehensive and multifaceted assessment, including otoscopy, audiometry, and nasal endoscopy. Balloon dilation of the Eustachian tube is contraindicated for individuals diagnosed with patulous Eustachian tube dysfunction. Other potentially treatable causes of Eustachian tube dysfunction, including allergic rhinitis, rhinosinusitis, and laryngopharyngeal reflux, should be identified and medically managed before balloon dilation is offered.

    Repeat balloon dilation procedures and indications other than treatment meeting the medically necessary criteria are investigational. There is not enough research to show that balloon dilation of the Eustachian tube improves health outcomes for people with any other indication or for repeat balloon dilation procedures.

    Balloon dilation of the Eustachian tube is considered not medically necessary when Criterion I is not met, including when any required criterion for medically necessary treatment is absent.

    Balloon dilation of the Eustachian tube is considered not medically necessary when policy criteria are not met because positive health outcomes have not been demonstrated for individuals who do not meet the individual selection criteria.

    Coding and Clinical Thresholds

    Regulatory device identifiersmixed
    PNZFDA product code for the AERA Eustachian tube balloon dilation device classification
    K163509FDA 510(k) clearance identifier for the AERA and XprESS Eustachian tube dilation devices
    CPTCPT
    69705Nasopharyngoscopy, surgical, with dilation of eustachian tube (ie, balloon dilation); unilateral Nasopharyngoscopy, surgical, with dilation of eustachian tube (ie, balloon dilation); bilateral
    HCPCSHCPCS
    69799Unlisted procedure, middle ear
    Duration of symptoms
    Required durationAt least 12 months
    Applicable conditionChronic obstructive Eustachian tube dysfunction
    Examples of symptomsAural fullness, aural pressure, otalgia, or hearing loss
    Nasal steroid trial
    TreatmentNasal steroid spray
    Trial duration4-6 weeks when indicated
    Applicable conditionsAllergic rhinitis, rhinosinusitis, and laryngopharyngeal reflux
    Tympanogram
    Required patternsType B or C
    Type BPoor tympanic membrane mobility; a flat tympanogram
    Type CNegative middle ear pressure
    ETDQ-7 score
    Threshold≥ 2.1
    ScaleMean item score ranging from 1.0 to 7.0
    UseAssesses Eustachian tube dysfunction-related symptoms over the previous month
    FDA-cleared pediatric age for AERA
    DeviceAERA Eustachian Tube Balloon Dilation System
    Pediatric FDA clearanceAge 8 years and older
    Approval timingAdditional FDA approval received in December 2023
    Original FDA-cleared age for AERA
    DeviceAERA Eustachian Tube Balloon Dilation System
    Original FDA clearanceAge 22 years and older
    Clearance timingCleared through the 510(k) process in January 2018

    Authorization and Documentation Requirements

    Documentation Required

    Clinical Documentation Required

    Submit clinical documentation supporting that the policy criteria are met. Missing information may affect the review and decision outcome.

    Step Therapy

    Failure of Medical Management

    Document failure to respond to appropriate medical management of co-occurring conditions, including a 4–6 week nasal steroid spray trial when indicated.

    • Include management of conditions such as allergic rhinitis, rhinosinusitis, and laryngopharyngeal reflux when applicable.
    Prior Authorization

    Pediatric Prior Surgical Intervention

    For individuals younger than 18 years, document refractoriness to at least one surgical intervention, such as tympanostomy tube placement.

    • Individuals age 18 years or older do not have this additional surgical-intervention requirement.
    Documentation Required

    Clinical History and Indication

    Submit the clinical history and indication for the requested service, including the duration of obstructive eustachian tube dysfunction signs and specific symptoms and how they have impaired function.

    • Document symptoms such as aural fullness, aural pressure, otalgia, or hearing loss and their duration.
    • Symptoms must have occurred for at least 12 months and be continuous rather than episodic.
    Denial Risk

    Contraindication Screening

    Document that patulous eustachian tube dysfunction and other contraindications have been evaluated and ruled out before requesting balloon dilation.

    • Screen for extrinsic or other causes of eustachian tube dysfunction, including craniofacial syndromes, neoplasms, prior nasopharyngeal radiation, enlarged adenoids, nasopharyngeal mass, neuromuscular disorders, and active systemic mucosal or autoimmune inflammatory disease.
    • Also rule out aural fullness with a normal examination and tympanogram and chronic severe atelectatic ears.
    Documentation Required

    Objective Diagnostic Findings

    Submit diagnostic findings from a comprehensive assessment documenting both an abnormal tympanogram and an abnormal tympanic membrane.

    • The tympanogram must be Type B or Type C.
    • Document tympanic membrane retraction, effusion, perforation, or another abnormality identified on examination.
    Step Therapy

    Failed Medical Management

    Document failure of medical management for each applicable co-occurring condition and specify the length of each treatment trial.

    • Relevant conditions include allergic rhinitis, rhinosinusitis, and laryngopharyngeal reflux.
    • Include documentation of a 4–6 week nasal steroid spray trial when indicated.
    Documentation Required

    Prior Tympanostomy Tube Response

    When there is a history of tympanostomy tube placement, document that symptoms of obstructive eustachian tube dysfunction improved while the tubes were patent.

    • If there is no history of tympanostomy tube placement, document that circumstance.
    Denial Risk

    Criteria Not Met

    Balloon dilation is not medically necessary when all Criterion I requirements for medically necessary treatment are not met.

    • Verify every applicable requirement before submitting the request.
    Denial Risk

    Repeat or Other Indications

    Repeat balloon dilation and balloon dilation for all other indications are investigational.

    • This includes requests outside the covered treatment of chronic obstructive eustachian tube dysfunction meeting Criterion I.
    Denial Risk

    Contraindications

    Do not request balloon dilation for contraindicated presentations, including patulous eustachian tube dysfunction, extrinsic causes of eustachian tube dysfunction, or aural fullness with a normal examination and tympanogram.

    • Other contraindications include chronic severe atelectatic ears and active extrinsic or systemic conditions affecting the eustachian tube.
    Denial Risk

    Policy Criteria Not Met

    The procedure is not medically necessary when the policy criteria are not met.

    • Submit documentation demonstrating that the individual meets the policy’s selection criteria.
    Denial Risk

    Other Indications or Repeat Procedures

    Balloon dilation is investigational when requested for an indication outside the covered treatment criteria or as a repeat procedure.

    • There is insufficient evidence that these uses improve health outcomes.
    Denial Risk

    Patulous Eustachian Tube Dysfunction

    Do not request balloon dilation for an individual diagnosed with patulous eustachian tube dysfunction; the procedure is contraindicated.

    • Potential patulous dysfunction symptoms include autophony of voice, audible respirations, pulsatile tinnitus, and/or aural fullness.

    Clinical Background

    The Eustachian tube connects the middle ear to the nasopharynx. It ventilates the middle ear, equalizes pressure, clears secretions, and helps protect against infection and reflux. When the tube does not open or close properly, Eustachian tube dysfunction may cause muffled hearing, ear fullness, tinnitus, vertigo, hearing loss, otitis media, tympanic membrane perforation, or cholesteatoma. Balloon dilation is a transnasal endoscopic tuboplasty in which a saline-filled balloon is placed in the cartilaginous Eustachian tube, maintained under pressure for approximately two minutes, then emptied and removed.

    Policy Definitions and Abbreviations

    Balloon dilation of the Eustachian tube
    Procedure typeTuboplasty procedure
    PurposeIntended to improve patency of the cartilaginous Eustachian tube
    TechniqueA saline-filled balloon catheter is introduced through the nose using a minimally invasive transnasal endoscopic method
    Chronic Eustachian tube dysfunction
    ConditionEustachian tube dysfunction
    DurationSymptoms and signs lasting more than 3 months
    Related classificationTransient Eustachian tube dysfunction lasts less than 3 months
    Type B tympanogram
    TracingFlat tympanogram
    IndicatesPoor tympanic membrane mobility
    MeasureTympanometry assesses tympanic membrane mobility
    Type C tympanogram
    TracingType C tympanogram
    IndicatesNegative middle ear pressure
    Clinical measureTympanometry is used to assess middle ear and Eustachian tube function
    ETDQ-7
    QuestionnaireSeven-item symptom questionnaire
    Score range1.0 to 7.0
    Assessment periodSymptoms over the previous month
    ETD
    AbbreviationETD
    MeaningEustachian tube dysfunction
    Clinical contextA disorder involving the function of the Eustachian tube
    BDET / BET / ETBD
    BDETBalloon dilation of the Eustachian tube
    BETBalloon Eustachian tuboplasty
    ETBDEustachian tube balloon dilation
    ETDQ-7
    Full nameEustachian Tube Dysfunction Questionnaire
    FormatSeven-item questionnaire
    PurposeAssesses patient-reported Eustachian tube dysfunction symptoms
    MM
    AbbreviationMM
    MeaningMedical management
    Policy contextMedical management may include treatment of co-occurring conditions
    Policy Summary
    PayerRegence
    PolicyBalloon Dilation of the Eustachian Tube
    Policy CodePolicy 206
    Change TypeNo material change
    Effective DateNovember 1, 2026
    Last ReviewOct 1, 2026
    Next Review DateMarch 1, 2027
    Key ActionSubmit clinical documentation supporting the medical policy criteria for review.
    SourceLink
    On This Page
    Medical Necessity and Coverage DeterminationsCoding and Clinical ThresholdsAuthorization and Documentation RequirementsClinical BackgroundPolicy Definitions and Abbreviations